New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 14, 2012
15:03 EDTJDSU, FACE, AMCN, MYGNCompanies reporting After the Market Close on Tuesday, August 14
Notable companies reporting after the bell include Airmedia Group (AMCN), JDS Uniphase (JDSU), Myriad Genetics (MYGN) and Physicians Formula Holdings (FACE).
News For AMCN;JDSU;MYGN;FACE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
08:30 EDTJDSUJDSU should be bought on weakness, says Stifel
Subscribe for More Information
January 29, 2015
19:14 EDTJDSUOn The Fly: After Hours Movers
Subscribe for More Information
18:04 EDTJDSUJDSU down nearly 5% following Q2 results, guidance
16:17 EDTJDSUJDSU sees Q3 EPS 9c plus or minus 2c, consensus 14c
Subscribe for More Information
16:14 EDTJDSUJDSU reports Q2 EPS 15c, consensus 16c
Subscribe for More Information
15:37 EDTJDSUNotable companies reporting after market close
Subscribe for More Information
09:21 EDTMYGNIridian Asset reports 5.5% passive stake in Myriad Genetics
08:31 EDTMYGNMyriad Genetics guidance at risk, says Morgan Stanley
Subscribe for More Information
January 28, 2015
13:01 EDTJDSUSandell Asset comments on recent amendments to JDSU bylaws
Subscribe for More Information
January 26, 2015
07:17 EDTMYGNSociety of Thoracic Surgeons to hold annual meeting
51st Annual Meeting of STS is being held in San Diego, California on January 24-28.
January 23, 2015
15:46 EDTMYGNPiper Jaffray's medtech analysts hold an analyst/industry conference call
Subscribe for More Information
January 20, 2015
07:07 EDTMYGNMyriad RBM joins Institut Pasteur in TB collaboration
Myriad RBM, a wholly owned subsidiary of Myriad Genetics, announced that it will assist the Institut Pasteur in a public-private research collaboration to fight the global tuberculosis, or TB, epidemic. This research project is funded by the Bill & Melinda Gates Foundation through a grant to the Institut Pasteur. The proof-of-concept study will evaluate patients with latent and active TB infections who are affiliated with the South African Tuberculosis Vaccine Initiative clinical study sites. The goals of this study are to field-test Myriad RBM's TruCulture system as a point-of-care blood collection and immune response monitoring method and to stratify patients with active and latent tuberculosis.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use